Skip to main content

ObsEva SA

OBSVDelisted Mar 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001685316

ObsEva SA was delisted on Mar 27, 2023; its insiders filed their last Form 4 on Apr 11, 2023; 27 institutions reported holding it in 13F filings for Q4 2022, worth $1.89M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding ObsEva SA changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of OBSV: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3427−7
Shares13.7M13.0M−647.9K (−4.7%)
Value$1.94M$1.89M−$50.8K (−2.6%)

New holders (2)

Institutions that held ObsEva SA at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to OBSV in Q4 2022
InstitutionSharesValue% of portfolio
Banque Pictet & Cie SA50,000$7.25K0.00%
HRT Financial LP21,788$3.00K0.00%

Sold out (9)

Institutions that held ObsEva SA at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of OBSV in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
BlackRock Inc.326,829$47.0K
Two Sigma Investments, LP177,133$25.0K
Renaissance Technologies LLC146,900$21.0K
Tower Research Capital LLC (TRC)35,191$5.00K
Goldman Sachs Group Inc31,421$4.00K
Howe & Rusling Inc290$0
Royal Bank of Canada1$0
Evoke Wealth, LLC33$0
China Universal Asset Management Co., Ltd.792$0